LMRI
Lumexa Imaging Holdings, Inc.
$8.13
-4.35%
$781.1M
No data for this timeframe.
Vol
Market Cap$781.1M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders5 funds
Inst. Value$17.4M
Inst. Activity4 buys / 0 sells
Insider Activity2B / 0S
Insider Net $$476.9K
SEC Reports2
Recent Activity
May 19, 2026
Insider
BRODNAX BRETT bought 35,000 shares
Director @ $7.25 ($253.8K)
May 14, 2026
Insider
Cooper Henry Lee bought 30,000 shares
Director @ $7.44 ($223.1K)
May 12, 2026
SEC
Lumexa Imaging reported Q1 2026 GAAP EPS of $0.02, a massive miss vs the $0.12 consensus, and revenue of $252.5M slightl
PRESS-RELEASE — Impact 7/10
May 12, 2026
SEC
Lumexa Imaging reported Q1 2026 revenue of $252.5M (+3.1% YoY), slightly above consensus of $251.2M, and GAAP EPS of $0.
8-K — Impact 4/10
Feb 25, 2026
Insider
Walker James Edward Jr. sold 12,414 shares
Principal Accounting Officer @ $0.00 ($0.00)
Inst.
FMR LLC — NEW
681,700 shares ($12.6M)
Inst.
VANGUARD GROUP INC — NEW
230,000 shares ($4.3M)
May 12, 2026
earnings
Lumexa Imaging Announces First Quarter 2026 Results
<p align="justify">RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI),
Price Targets
$17.29
+99.8% upside
Strong Buy
Current $8.65
Low $9.00
Median $18.00
High $23.00
7 analysts
$9.00
$23.00
Analyst Ratings
6Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 20, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| Feb 9, 2026 | Raymond James | UPGRADE | Outperform → Strong Buy |
| Jan 5, 2026 | Raymond James | INITIATE | Outperform |
| Jan 5, 2026 | Barclays | INITIATE | Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.14 | $0.10 — $0.16 | 5 | |
| Next Q | $0.19 | $0.16 — $0.21 | 5 | |
| Current FY | $0.70 | $0.49 — $0.77 | 291% YoY | 5 |
| Next FY | $0.89 | $0.79 — $1.06 | 27% YoY | 5 |
Latest Reports
BEARISH
PRESS-RELEASE
7/10
Lumexa Imaging reported Q1 2026 GAAP EPS of $0.02, a massive miss vs the $0.12 consensus, and revenue of $252.5M slightl
May 12, 2026
NEUTRAL
8-K
4/10
Lumexa Imaging reported Q1 2026 revenue of $252.5M (+3.1% YoY), slightly above consensus of $251.2M, and GAAP EPS of $0.
May 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | $12.6M | NEW |
| VANGUARD GROUP INC | $4.3M | NEW |
| MORGAN STANLEY | $324.4K | NEW |
| TWO SIGMA INVESTMENTS, LP | $249.8K | NEW |
| BANK OF AMERICA CORP | $111.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 19, 2026 | BRODNAX BRETT | BUY | $253.8K |
| May 14, 2026 | Cooper Henry | BUY | $223.1K |
| Feb 25, 2026 | Walker James | A | $0.00 |
5 institutional holders with $17.4M total value (942,739 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, MORGAN. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | 681,700 | $12.6M | 72.3% | NEW |
| 2 | VANGUARD GROUP INC | 230,000 | $4.3M | 24.4% | NEW |
| 3 | MORGAN STANLEY | 17,533 | $324.4K | 1.9% | NEW |
| 4 | TWO SIGMA INVESTMENTS, LP | 13,500 | $249.8K | 1.4% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 6 | $111.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | NEW | — | 681,700 | — | $12.6M | 2025-Q4 |
| VANGUARD GROUP INC | NEW | — | 230,000 | — | $4.3M | 2025-Q4 |
| MORGAN STANLEY | NEW | — | 17,533 | — | $324.4K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 13,500 | — | $249.8K | 2025-Q4 |
3 unique insiders with 2 transactions. Net insider value: $476.9K ($476.9K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 19, 2026 | BRODNAX BRETT | Director | BUY | 35,000 | $7.25 | $253.8K |
| May 14, 2026 | Cooper Henry Lee | Director | BUY | 30,000 | $7.44 | $223.1K |
| Feb 25, 2026 | Walker James Edward Jr. | Principal Accounting Officer | A | 12,414 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (93% buy). Based on 14 analysts: 6 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$17.29 mean target
+99.8% upside
Strong Buy (1.25)
$9.00 Low
$23.00 High
| Metric | Value |
|---|---|
| Current Price | $8.65 |
| Target Low | $9.00 |
| Target Mean | $17.29 |
| Target Median | $18.00 |
| Target High | $23.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (1.25) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.14 | $0.10 | $0.16 | — | — | 1↑ 4↓ | $0.3B | — | 5 |
| Next Q 2026-09-30 |
$0.19 | $0.16 | $0.21 | — | — | 2↑ 2↓ | $0.3B | — | 5 |
| Current FY 2026-12-31 |
$0.70 | $0.49 | $0.77 | 290.9% | — | 2↑ 2↓ | $1.1B | 4.3% | 5 |
| Next FY 2027-12-31 |
$0.89 | $0.79 | $1.06 | 27.4% | — | 2↑ 2↓ | $1.1B | 5.5% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.142 | |
| 7d ago | $0.163 | -0.021 |
| 30d ago | $0.000 | +0.142 |
| 60d ago | $0.161 | -0.019 |
| 90d ago | $0.172 | -0.030 |
7 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 7 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 20, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Feb 9, 2026 | Raymond James | UPGRADE | Outperform | Strong Buy |
| Jan 5, 2026 | Raymond James | INITIATE | — | Outperform |
| Jan 5, 2026 | Barclays | INITIATE | — | Overweight |
| Jan 5, 2026 | Wells Fargo | INITIATE | — | Overweight |
| Jan 5, 2026 | William Blair | INITIATE | — | Outperform |
| Jan 5, 2026 | Deutsche Bank | INITIATE | — | Buy |
| Jan 5, 2026 | Leerink Partners | INITIATE | — | Outperform |
| Jan 5, 2026 | Jefferies | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 7 | 1 | 0 | 0 | 93% | |
| May 1, 2026 | 6 | 7 | 1 | 0 | 0 | 93% | |
| Apr 1, 2026 | 6 | 7 | 1 | 0 | 0 | 93% | |
| Mar 1, 2026 | 4 | 7 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 12, 2026
earnings
Lumexa Imaging Announces First Quarter 2026 Results
<p align="justify">RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatien
May 12, 2026
earnings_calendar
LMRI Q1 2026 Earnings Scheduled — 2026-05-12
Apr 28, 2026
earnings
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
<p align="justify">RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4pMVR2FjpPusR61cyoQsY1uu-54
Apr 20, 2026
other
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging’s platform <pre>Proven healthcare growth le
Apr 1, 2026
short_volume
Short Volume: LMRI — 78.8% short (0.6M / 0.8M)
Short: 643,919 | Exempt: 1,000 | TRF Vol: 816,808 | Short Ratio: 78.8% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
short_volume
Short Volume: LMRI — 71.0% short (0.6M / 0.9M)
Short: 617,716 | Exempt: 57,539 | TRF Vol: 869,833 | Short Ratio: 71.0% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
earnings
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
<p align="justify">RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpati
Mar 26, 2026
short_volume
Short Volume: LMRI — 65.3% short (0.8M / 1.2M)
Short: 805,876 | Exempt: 34,706 | TRF Vol: 1,233,591 | Short Ratio: 65.3% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
earnings_calendar
LMRI Q4 2025 Earnings Scheduled — 2026-03-26
Mar 25, 2026
short_interest
FTD: LMRI — 95,971 shares ($1.0M) failed to deliver
Settlement: 20260325, Price: $10.84, FTD Value: $1,040,325.64, LUMEXA IMAGING HLDGS INC COM
Mar 23, 2026
short_interest
FTD: LMRI — 482,612 shares ($5.7M) failed to deliver
Settlement: 20260323, Price: $11.84, FTD Value: $5,714,126.08, LUMEXA IMAGING HLDGS INC COM